Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry
Maximilian Preiß, Valentin Popper, Luna Helene Charlotte Faber, Tg Baumgartner, Philip Miguel Baberis-Martinez, Edda Pjrek, Gregor Gryglewski, Lucie Bartova, Siegfried Kasper, Dan Rujescu, Lukas Pezawas
European Psychiatry June 23, 2026 DOI: 10.1192/j.eurpsy.2026.12234 via OpenAlex
Study at a glance
| Characteristics | Observational Peer reviewed |
|---|---|
| Population | Patients with TRD from the enTRD registry |
| Keywords | Nasal administration Action physics Onset of action Adverse effect Anesthesia |
| Key finding | Real-world data from the enTRD registry show effectiveness and safety of intranasal esketamine for TRD. |
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.